RxDoctor Payments Data

Dacin Schoenborn, PA

Physician Assistant · Warren, PANPI 1124546692

Payments from drug & device makers

$616in general payments, 2019–2025

Across 36 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$141
  • GSK$100
  • Pfizer$53
  • Lilly USA, LLC$52
  • Novo Nordisk$48
  • AbbVie$44
  • plus $177 from 7 others

What the payments were for

  • Food & beverage$616100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$616 in reported general payments places this provider in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$12,871
Medicare patients
112
Services billed
148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide56$65,907
OzempicSemaglutide55$61,318
EliquisApixaban41$40,187
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$36,313
XareltoRivaroxaban28$32,633
JanuviaSitagliptin Phosphate20$21,209
RybelsusSemaglutide16$21,113
JardianceEmpagliflozin14$17,666
LinzessLinaclotide18$15,387
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$8,865
Spiriva RespimatTiotropium Bromide15$7,848
Aimovig AutoinjectorErenumab-Aooe11$7,322
TradjentaLinagliptin14$6,634
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$5,568
Novolog FlexpenInsulin Aspart25$4,778

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$48$82,43171 claims
Lilly USA, LLCTrulicity$52$65,90756 claims
PfizerEliquis$53$40,18741 claims
GSKTrelegy Ellipta$100$36,31348 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$16$32,14843 claims
AbbVieLinzess, Synthroid$44$17,04745 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Warren

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →